Breaking

Trump Announces Deal to End US-Iran War, Lift Strait of Hormuz Blockade Russian Attacks Kill 5 Rescuers in Kharkiv, Wound 20 in Kyiv; Landmarks Hit KFC Revamps Menu and Stores to Compete in Crowded Chicken Market UK to Ban Under-16s From Social Media Apps Like TikTok and Snapchat X-Men '97 vs. Masters of the Universe: A Tale of Nostalgia and Neglect Parents Increasingly Track Adult Children Via Smartphone Apps, Survey Finds World Cup Kicks Off With Thrilling Matches and Surprises Political Campaigns Grapple with Influencer Strategy: Mixed Results in Turning Online Buzz into Votes Ebola Outbreak in Eastern Congo: Challenges and Fear in Ituri Province Marius Borg Høiby, Son of Norway's Crown Princess, Sentenced to 4 Years for Rape Trump Announces Deal to End US-Iran War, Lift Strait of Hormuz Blockade Russian Attacks Kill 5 Rescuers in Kharkiv, Wound 20 in Kyiv; Landmarks Hit KFC Revamps Menu and Stores to Compete in Crowded Chicken Market UK to Ban Under-16s From Social Media Apps Like TikTok and Snapchat X-Men '97 vs. Masters of the Universe: A Tale of Nostalgia and Neglect Parents Increasingly Track Adult Children Via Smartphone Apps, Survey Finds World Cup Kicks Off With Thrilling Matches and Surprises Political Campaigns Grapple with Influencer Strategy: Mixed Results in Turning Online Buzz into Votes Ebola Outbreak in Eastern Congo: Challenges and Fear in Ituri Province Marius Borg Høiby, Son of Norway's Crown Princess, Sentenced to 4 Years for Rape

MHRA

Steady2 stories2 sourcesLast updated: 3d ago

Related TopicsWegovy semaglutide obesity weight loss GLP-1 receptor agonist Novo Nordisk BMI NHS

Latest Stories

UK Approves Wegovy Weight-Loss Pill, Expanding Obesity Treatment Options

3d agoAI summary

UK Approves Wegovy Weight-Loss Pill, Expanding Obesity Treatment Options

The UK's MHRA has approved Wegovy, the first GLP-1 receptor agonist tablet for weight loss, making the UK the third country to authorize the pills. This expands treatment options for adults with obesity or overweight with related health conditions.

UK Approves First GLP-1 Receptor Agonist Tablet for Weight Management

3d agoAI summary

UK Approves First GLP-1 Receptor Agonist Tablet for Weight Management

The UK's MHRA has approved the first GLP-1 receptor agonist tablet, semaglutide (Wegovy), for weight loss and management. This daily pill offers a more convenient alternative to weekly injections for adults with obesity or those overweight with weight-related conditions.